Literature DB >> 17591971

Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.

Liqin Zhu1, Guanglu Shi, C Max Schmidt, Ralph H Hruban, Stephen F Konieczny.   

Abstract

A number of studies have shown that pancreatic ductal adenocarcinoma develops through precursor lesions termed pancreatic intraepithelial neoplasia (PanIN). PanINs are thought to initiate in the small ducts of the pancreas through activating mutations in the KRAS proto-oncogene. What remains unanswered is the identification of the individual cell type(s) that contributes to pancreatic ductal adenocarcinoma formation. To follow the cellular and molecular changes that occur in acinar and duct cell properties on Kras(G12D) expression, we took advantage of LSL-Kras(G12D/+)/p48(Cre/+) mice, which faithfully mimic the human disease. In young animals (4 weeks), the predominant cellular alteration in the exocrine pancreas was acinar metaplasia in which individual acini consisted of acinar cells and duct-like cells. Metaplastic acinar structures were highly proliferative, expressed Notch target genes, and exhibited mosaic expression patterns for epidermal growth factor receptor, ErbB2, and pErk. This expression pattern paralleled the expression pattern detected in mouse PanINs, suggesting that mouse PanINs and acinar-ductal metaplasia follow similar molecular pathways. Indeed, immunofluorescence studies confirmed the presence of acinar cells within mPanIN lesions, raising the possibility that Kras(G12D)-induced mPanINs develop from acinar cells that undergo acinar-ductal metaplasia. Identification of an acinar contribution to PanIN formation offers new directions for successful targeted therapeutic approaches to combat this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591971      PMCID: PMC1941579          DOI: 10.2353/ajpath.2007.061176

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Transdifferentiation and metaplasia--switching cell types.

Authors:  J M Slack; D Tosh
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

Review 2.  How cells change their phenotype.

Authors:  David Tosh; Jonathan M W Slack
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 3.  Focus on pancreas cancer.

Authors:  Elizabeth M Jaffee; Ralph H Hruban; Marcia Canto; Scott E Kern
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

4.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

5.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.

Authors:  Yoshiharu Miyamoto; Anirban Maitra; Bidyut Ghosh; Ulrich Zechner; Pedram Argani; Christine A Iacobuzio-Donahue; Virote Sriuranpong; Tatsuya Iso; Ingrid M Meszoely; Michael S Wolfe; Ralph H Hruban; Douglas W Ball; Roland M Schmid; Steven D Leach
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

6.  Notch signaling controls multiple steps of pancreatic differentiation.

Authors:  L Charles Murtaugh; Ben Z Stanger; Kristen M Kwan; Douglas A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.

Authors:  Felix H Brembeck; Franz S Schreiber; Therese B Deramaudt; Linden Craig; Ben Rhoades; Gary Swain; Paul Grippo; Doris A Stoffers; Debra G Silberg; Anil K Rustgi
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development.

Authors:  Jacob Hald; J Peter Hjorth; Michael S German; Ole D Madsen; Palle Serup; Jan Jensen
Journal:  Dev Biol       Date:  2003-08-15       Impact factor: 3.582

9.  The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors.

Authors:  Yoshiya Kawaguchi; Bonnie Cooper; Maureen Gannon; Michael Ray; Raymond J MacDonald; Christopher V E Wright
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

10.  The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity.

Authors:  C L Pin; J M Rukstalis; C Johnson; S F Konieczny
Journal:  J Cell Biol       Date:  2001-11-05       Impact factor: 10.539

View more
  118 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia.

Authors:  Li Ding; Geou-Yarh Liou; Daniel M Schmitt; Peter Storz; Jin-San Zhang; Daniel D Billadeau
Journal:  J Pathol       Date:  2017-07-27       Impact factor: 7.996

Review 4.  Cells of origin of pancreatic neoplasms.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2017-03-04       Impact factor: 2.549

Review 5.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

6.  Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.

Authors:  Helen Court; Marc Amoyel; Michael Hackman; Kyoung Eun Lee; Ruliang Xu; George Miller; Dafna Bar-Sagi; Erika A Bach; Martin O Bergö; Mark R Philips
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

7.  Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.

Authors:  Chen Liang; Zhen Wang; Li Wu; Chen Wang; Bao-Hua Yu; Xiu-Zhong Yao; Xiao-Lin Wang; Ying-Yi Li
Journal:  Tumour Biol       Date:  2015-04-29

8.  Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras.

Authors:  Catherine Carrière; Alison L Young; Jason R Gunn; Daniel S Longnecker; Murray Korc
Journal:  Biochem Biophys Res Commun       Date:  2009-03-16       Impact factor: 3.575

9.  Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.

Authors:  E Scott Seeley; Catherine Carrière; Tobias Goetze; Daniel S Longnecker; Murray Korc
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.

Authors:  Jean-Paul De La O; L Charles Murtaugh
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.